U.S. Sen. Alex Padilla visited UC Irvine on September 8 to learn about university research initiatives. The focus of the visit was to understand how UC Irvine’s work is improving health outcomes, driving innovation, and progressing the search for new treatments for Alzheimer’s disease and other forms of dementia.
During his time on campus, Senator Padilla met with campus leaders to receive presentations on various aspects of UC Irvine’s efforts, including its comprehensive research portfolio, UCI Health, Beall Applied Innovation, and UCI MIND. Following these discussions, he toured a UCI MIND laboratory. UCI MIND serves as UC Irvine’s interdisciplinary research center, dedicated to the understanding, diagnosis, treatment, and ultimate prevention of Alzheimer’s disease and other forms of dementia.
Senator Padilla noted that federally funded research at universities nationwide contributes to shaping the future of health and technology. He specifically highlighted that researchers at the UCI MIND laboratory are advancing significant medical breakthroughs for millions of Americans. Padilla expressed honor in meeting with UCI Health researchers to gain a better understanding of their innovative work in supporting patients and families affected by Alzheimer’s disease and related dementias, and to identify how Congress can support research that makes a meaningful difference in their lives.
Aileen Anderson, Vice Chancellor for Research, addressed the importance of consistent federal investment in university research. She stated that uncertainty in the funding pipeline can make it difficult to maintain essential laboratories, sustain research programs, and preserve opportunities for students. Anderson also underscored the vital role that academic research centers play in transitioning discoveries from basic research stages through clinical trials and, ultimately, to patients in need.
Dr. Michael Stamos, Interim Vice Chancellor for Health Affairs and Dean of the School of Medicine, provided details on UCI Health’s expanding network of hospitals and clinics. He also discussed UC Irvine’s four health sciences schools—medicine, nursing, pharmacy, and public health—and explained how robust translational and clinical research in these disciplines is leading to new discoveries, products, treatments, and cures, while simultaneously preparing the next generation of healthcare professionals.
Errol Arkilic, UC Irvine’s Chief Innovation Officer, highlighted the university’s established infrastructure for translating research discoveries into marketable products and services. He described the ongoing efforts to move innovations from the laboratory to the marketplace, touching upon areas such as medical devices, artificial intelligence, aerospace, and national security. Arkilic cited several examples of UC Irvine technologies currently advancing toward commercialization.
Joshua Grill, Director of UCI MIND, presented recent advancements in Alzheimer’s research. These included developments in PET imaging, the introduction of blood-based testing, and new treatment options. Grill also discussed ongoing efforts to increase Latino participation in clinical trials related to Alzheimer's disease.
Overall, the visit provided UC Irvine with an opportunity to demonstrate how research conducted at public universities can improve the health and quality of life for Americans. Anderson concluded by expressing appreciation for Senator Padilla’s visit and his direct interest in hearing from the researchers about their work, reiterating the significant role public research universities play in enhancing the health and well-being of all Americans.
